Abstract
It has been previously reported that miRNA regulations were involved in various biological processes. The deregulation activities of microRNA regulators potentially contribute to the pathopoiesis of various kinds of human cancers, and are candidate biomarkers for cancer diagnosis and prognosis. Until now, enormous studies have been conducted to explore potential miRNA biomarkers for different types of cancers. In this chapter, we will first provide a brief introduction about miRNAs biogenesis and their involvement in cancer pathopoiesis, and then reviewed the advances on current available miRNA profiling technologies. Then concise text will be exploited to describe the traditional experiment-dominate approaches for miRNA biomarker discovery. In the next part, intensive efforts are made on the review and summarization of miRNA–mRNA network based computational methods for the discovery of potential miRNA biomarkers. Afterwards, collect and list exsiting online databases relating to cancer miRNA biomarker discovery. Finally, we propose the perspective directions on this research area, and conclude the main context in this chapter.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Ahmed FE. Role of miRNA in carcinogenesis and biomarker selection: a methodological view. Expert Rev Mol Diagn. 2007;7(5):569–603.
Ambros V. The functions of animal microRNAs. Nature. 2004;431(7006):350–5.
Arora A, Simpson DA. Individual mRNA expression profiles reveal the effects of specific microRNAs. Genome Biol. 2008;9(5):R82.
Babak T, Zhang W, Morris Q, Blencowe BJ, Hughes TR. Probing microRNAs with microarrays: tissue specificity and functional inference. RNA. 2004;10(11):1813–9.
Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–97.
Bielekova B, Martin R. Development of biomarkers in multiple sclerosis. Brain J Neurol. 2004;127(Pt 7):1463–78.
Bonnet E, Tatari M, Joshi A, Michoel T, Marchal K, Berx G, Van de Peer Y. Module network inference from a cancer gene expression data set identifies microRNA regulated modules. PLoS One. 2010;5(4):e10162.
Cheng C, Li LM. Inferring microRNA activities by combining gene expression with microRNA target prediction. PLoS One. 2008;3(4):e1989.
Doledec S, Chessel D. Co-inertia analysis: an alternative method for studying species environment relationships. Freshw Biol. 1994;31(3):277–94.
Dray S, Chessel D, Thioulouse J. Co-inertia analysis and the linking of ecological data tables. Ecol. 2003;84(11):3078–89.
Dugas DV, Bartel B. MicroRNA regulation of gene expression in plants. Curr Opin Plant Biol. 2004;7(5):512–20.
Enright AJ, John B, Gaul U, Tuschl T, Sander C, Marks DS. MicroRNA targets in Drosophila. Genome Biol. 2003;5(1):R1.
Gall JG, Pardue ML. Formation and detection of RNA–DNA hybrid molecules in cytological preparations. Proc Natl Acad Sci USA. 1969;63(2):378–83.
Gao W, Lu X, Liu L, Xu J, Feng D, Shu Y. MiRNA-21: a biomarker predictive for platinum-based adjuvant chemotherapy response in patients with non-small cell lung cancer. Cancer Biol Ther. 2012;13(5):330–40.
Griffiths-Jones S. The microRNA registry. Nucleic acids Res. 2004;32(Database issue):D109–11.
Guerau-de-Arellano M, Alder H, Ozer HG, Lovett-Racke A, Racke MK. miRNA profiling for biomarker discovery in multiple sclerosis: from microarray to deep sequencing. J Neuroimmunol. 2012;248(1–2):32–9.
Heneghan HM, Miller N, Kelly R, Newell J, Kerin MJ. Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease. Oncologist. 2010;15(7):673–82.
Hsu SD, Lin FM, Wu WY, Liang C, Huang WC, Chan WL, Tsai WT, Chen GZ, Lee CJ, Chiu CM et al. miRTarBase: a database curates experimentally validated microRNA–target interactions. Nucleic Acids Res. 2011;39(Database issue):D163–D169.
Jay C, Nemunaitis J, Chen P, Fulgham P, Tong AW. miRNA profiling for diagnosis and prognosis of human cancer. DNA Cell Biol. 2007;26(5):293–300.
Jayaswal V, Lutherborrow M, Ma DD, Yang YH. Identification of microRNA–mRNA modules using microarray data. BMC genomics. 2011;12:138.
Jiang Q, Wang Y, Hao Y, Juan L, Teng M, Zhang X, Li M, Wang G, Liu Y. miR2Disease: a manually curated database for microRNA deregulation in human disease. Nucleic Acids Res. 2009;37(Database issue): D98–104.
Joung JG, Hwang KB, Nam JW, Kim SJ, Zhang BT. Discovery of microRNA–mRNA modules via population-based probabilistic learning. Bioinformatics. 2007;23(9):1141–7.
Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, et al. Combinatorial microRNA target predictions. Nat Genet. 2005;37(5):495–500.
Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, Stoffel M. Silencing of microRNAs in vivo with ‘antagomirs’. Nature. 2005;438(7068):685–9.
Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75(5):843–54.
Lee Y, Kim M, Han J, Yeom KH, Lee S, Baek SH, Kim VN. MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 2004;23(20):4051–60.
Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120(1):15–20.
Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. Prediction of mammalian microRNA targets. Cell. 2003;115(7):787–98.
Li C, Li JF, Cai Q, Qiu QQ, Yan M, Liu BY, Zhu ZG. MiRNA-199a-3p in plasma as a potential diagnostic biomarker for gastric cancer. Annals Surg Oncol. 2012.
Li C, Li JF, Cai Q, Qiu QQ, Yan M, Liu BY, Zhu ZG. MiRNA-199a-3p: a potential circulating diagnostic biomarker for early gastric cancer. J Surg Oncol. 2013;108(2):89–92.
Lian H. MOST: detecting cancer differential gene expression. Biostatistics. 2008;9(3):411–8.
Lin SL, Kim H, Ying SY. Intron-mediated RNA interference and microRNA (miRNA). Front Biosci : J Virtual Libr. 2008;13:2216–30.
Liu B, Liu L, Tsykin A, Goodall GJ, Green JE, Zhu M, Kim CH, Li J. Identifying functional miRNA-mRNA regulatory modules with correspondence latent dirichlet allocation. Bioinformatics. 2010;26(24):3105–11.
Long M. Side effects of Tamiflu: clues from an Asian single nucleotide polymorphism. Cell Res. 2007;17(4):309–10.
Lu L, Li Y, Li S. Computational identification of potential microRNA network biomarkers for the progression stages of gastric cancer. Int J Data Min Bioinform. 2011;5(5):519–31.
MacDonald JW, Ghosh D. COPA–cancer outlier profile analysis. Bioinformatics. 2006;22(23):2950–1.
Madden SF, Carpenter SB, Jeffery IB, Bjorkbacka H, Fitzgerald KA, O’Neill LA, Higgins DG. Detecting microRNA activity from gene expression data. BMC Bioinform. 2010;11:257.
Maute RL, Schneider C, Sumazin P, Holmes A, Califano A, Basso K, Dalla-Favera R. tRNA-derived microRNA modulates proliferation and the DNA damage response and is down-regulated in B cell lymphoma. Proc Natl Acad Sci USA. 2013;110(4):1404–9.
Place RF, Li LC, Pookot D, Noonan EJ, Dahiya R. MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci USA. 2008;105(5):1608–13.
Ramshankar V, Krishnamurthy A. Lung cancer detection by screening—presenting circulating miRNAs as a promising next generation biomarker breakthrough. Asian Pac J Cancer Prev: APJCP. 2013;14(4):2167–72.
Raponi M, Dossey L, Jatkoe T, Wu X, Chen G, Fan H, Beer DG. MicroRNA classifiers for predicting prognosis of squamous cell lung cancer. Cancer Res. 2009;69(14):5776–83.
Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, Rougvie AE, Horvitz HR, Ruvkun G. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature. 2000;403(6772):901–6.
Ruepp A, Kowarsch A, Schmidl D, Buggenthin F, Brauner B, Dunger I, Fobo G, Frishman G, Montrone C, Theis FJ. PhenomiR: a knowledgebase for microRNA expression in diseases and biological processes. Genome Biol. 2010;11(1):R6.
Ruepp A, Kowarsch A, Theis F. PhenomiR: microRNAs in human diseases and biological processes. Methods Mol Biol. 2012;822:249–60.
Sarver AL, French AJ, Borralho PM, Thayanithy V, Oberg AL, Silverstein KA, Morlan BW, Riska SM, Boardman LA, Cunningham JM, et al. Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states. BMC Cancer. 2009;9:401.
Sarver AL, Phalak R, Thayanithy V, Subramanian S. S-MED: sarcoma microRNA expression database. Lab Inv; J Tech Methods Pathol. 2010;90(5):753–61.
Schopman NC, Heynen S, Haasnoot J, Berkhout B. A miRNA–tRNA mix-up: tRNA origin of proposed miRNA. RNA Biol. 2010;7(5):573–6.
Sethupathy P, Corda B, Hatzigeorgiou AG. TarBase: a comprehensive database of experimentally supported animal microRNA targets. RNA. 2006;12(2):192–7.
Tibshirani R, Hastie T. Outlier sums for differential gene expression analysis. Biostatistics. 2007;8(1):2–8.
Tran DH, Satou K, Ho TB. Finding microRNA regulatory modules in human genome using rule induction. BMC Bioinform. 2008;9(Suppl 12):S5.
Tran DH, Satou K, Ho TB, Pham TH. Computational discovery of miR-TF regulatory modules in human genome. Bioinformation. 2010;4(8):371–7.
Wang X, Wang X. Systematic identification of microRNA functions by combining target prediction and expression profiling. Nucleic Acids Res. 2006;34(5):1646–52.
Wightman B, Ha I, Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell. 1993;75(5):855–62.
Wu B. Cancer outlier differential gene expression detection. Biostatistics. 2007;8(3):566–75.
Xiao F, Zuo Z, Cai G, Kang S, Gao X, Li T. miRecords: an integrated resource for microRNA-target interactions. Nucleic Acids Res. 2009;37(Database issue):D105–110.
Xie B, Ding Q, Han H, Wu D. miRCancer: a microRNA-cancer association database constructed by text mining on literature. Bioinformatics. 2013;29(5):638–44.
Xu J, Li CX, Lv JY, Li YS, Xiao Y, Shao TT, Huo X, Li X, Zou Y, Han QL, et al. Prioritizing candidate disease miRNAs by topological features in the miRNA target-dysregulated network: case study of prostate cancer. Mol Cancer Ther. 2011;10(10):1857–66.
Yang Z, Ren F, Liu C, He S, Sun G, Gao Q, Yao L, Zhang Y, Miao R, Cao Y, et al. dbDEMC: a database of differentially expressed miRNAs in human cancers. BMC Genomics. 2010;11(Suppl 4):S5.
Yoon S, De Micheli G. Prediction and analysis of human microRNA regulatory modules. In: Conference proceedings: annual international conference of the IEEE Engineering in Medicine and Biology Society conference; 2005a, vol 5, p. 4799–802.
Yoon S, De Micheli G . Prediction of regulatory modules comprising microRNAs and target genes. Bioinformatics. 2005b;21 Suppl 2:ii93–100.
Zhang S, Li Q, Liu J, Zhou XJ. A novel computational framework for simultaneous integration of multiple types of genomic data to identify microRNA-gene regulatory modules. Bioinformatics. 2011;27(13):i401–9.
Zhang WY, Zang J, Jing XH, Sun ZD, Yang DR, Guo F, Shen BR. Identification of candidate cancer miRNA biomarkers from miRNA regulatory network: with application to prostate cancer. RNA. 2013 (submitted).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Zhang, W., Shen, B. (2013). Identification of Cancer MicroRNA Biomarkers Based on miRNA–mRNA Network. In: Shen, B. (eds) Bioinformatics for Diagnosis, Prognosis and Treatment of Complex Diseases. Translational Bioinformatics, vol 4. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-7975-4_8
Download citation
DOI: https://doi.org/10.1007/978-94-007-7975-4_8
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-7974-7
Online ISBN: 978-94-007-7975-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)